Article
Tumor suppressor function of Gata2 in acute promyelocytic leukemia.
Blood - 30 Sept 2021
Katerndahl Casey D S, Rogers Olivia R S, Day Ryan B, Cai Michelle A, Rooney Timothy P, Helton Nichole M, Hoock Mieke, Ramakrishnan Sai Mukund, Nonavinkere Srivatsan Sridhar, Wartman Lukas D, Miller Christopher A, Ley Timothy J
Abstract excerpt
Most patients with acute promyelocytic leukemia (APL) can be cured with combined all-trans retinoic acid (ATRA) and arsenic trioxide therapy, which induces the destruction of PML-RARA, the initiating fusion protein for this disease. However, the underlying mechanisms by which PML-RARA initiates and maintains APL cells are still not clear. Therefore, we identified genes that are dysregulated by PML-RARA in mouse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
